In this episode of Pathfinders, Brian Abrahams, Managing Director and Co-Head of Biotechnology Equity Research at RBC Capital Markets speaks with Andy Schwab, Co-Founder and Managing Partner at 5AM Ventures.

Key Points

• Prescription Digital Therapeutics will be vital to future treatment
• Unlocking microbiome could lead to better disease management